Enterprise Therapeutics granted EMA orphan medicinal product designation for novel cystic fibrosis therapy, ETD001 - News-Medical
2distinct sources
1country
1language
03:00detected Nov 17 (09:00 UTC)
06:34latest update, Nov 17
2articles
Publication chain
First published by Business Wire (Malaysia) on Nov 17 at 03:00 (09:00 UTC). Within 4 h it was covered by 2 outlets from 1 country.
- 03:00Nov 17, 09:00 UTC
-
06:34Nov 17, 12:34 UTC
NMNews-Medical news-medical.netEnterprise Therapeutics granted EMA orphan medicinal product designation for novel cystic fibrosis therapy, ETD001 - News-Medical
MY EN
Data for this story: JSON






